
Inflammatix uses AI built with H2O to read the immune system's gene-expression response, telling bacterial from viral infection from a blood sample in about 30 minutes at the point of care.
Sepsis kills an estimated 11 million people a year, and the gold-standard blood culture misses the pathogen in nearly half of cases and can take days. Inflammatix reads the immune system's own gene-expression response with AI built on H2O, differentiating bacterial infection, viral infection, and non-infectious inflammation from a blood sample in about 30 minutes at the point of care.
Inflammatix is a host-response diagnostics company based in Sunnyvale, California, that reads the immune system's own genetic response to diagnose acute infection and sepsis. Its first-in-class TriVerity test received FDA clearance in January 2025, returning results in about 30 minutes.
Inflammatix partners with H2O.ai on the machine learning behind its host-response approach. Learn more at https://inflammatix.com.